4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-030752
Chief Scientific Officer sold 3,895 shares at an average $36.14 ($140,748)
- Chief Scientific Officer acquired 3,895 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-04 | Option exercise | +3,895 | $6.32 | $24,616 | 73,255 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-04 | Sale | −3,195 | $35.99 | $114,988 | 70,060 | D |
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-04 | Sale | −700 | $36.80 | $25,760 | 69,360 | D |
| Derivatives | |||||||
| ROBINS HARLAN S Chief Scientific Officer | 2021-05-04 | Option exercise · Stock Option (Right to Buy) | −3,895 | 136,325 | D | ||
| Open-market sales · 3,895 sh · avg $36.14 · $140,748 | |||||||
Loading xslF345X03/doc4.xml…